102 related articles for article (PubMed ID: 14575358)
21. No increase in breast cancer risk in Japanese women taking oral contraceptives: a case-control study investigating reproductive, menstrual and familial risk factors for breast cancer.
Ichida M; Kataoka A; Tsushima R; Taguchi T
Asian Pac J Cancer Prev; 2015; 16(9):3685-90. PubMed ID: 25987022
[TBL] [Abstract][Full Text] [Related]
22. Correlates of oral contraceptive use in Italian women, 1991-93.
Parazzini F; Negri E; Ricci E; Franceschi S; La Vecchia C
Contraception; 1996 Aug; 54(2):101-6. PubMed ID: 8842587
[TBL] [Abstract][Full Text] [Related]
23. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
24. Oral contraceptive use and BRCA penetrance: a case-only study.
Pasanisi P; Hédelin G; Berrino J; Chang-Claude J; Hermann S; Steel M; Haites N; Hart J; Peled R; Gafà L; Leggio L; Traina A; Amodio R; Primic-Zakelj M; Zadnik V; Veidebaum T; Tekkel M; Berrino F
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2107-13. PubMed ID: 19549808
[TBL] [Abstract][Full Text] [Related]
25. A case-control study of the risk of breast cancer in relation to oral contraceptive use.
Rosenberg L; Palmer JR; Clarke EA; Shapiro S
Am J Epidemiol; 1992 Dec; 136(12):1437-44. PubMed ID: 1288273
[TBL] [Abstract][Full Text] [Related]
26. Oral contraceptives and breast cancer.
Brinton LA; Hoover R; Szklo M; Fraumeni JF
Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
[TBL] [Abstract][Full Text] [Related]
27. Age-specific differences in the relationship between oral contraceptive use and breast cancer.
Wingo PA; Lee NC; Ory HW; Beral V; Peterson HB; Rhodes P
Cancer; 1993 Feb; 71(4 Suppl):1506-17. PubMed ID: 8431887
[TBL] [Abstract][Full Text] [Related]
28. Breast cancer and oral contraceptive use.
Rosenberg L; Miller DR; Kaufman DW; Helmrich SP; Stolley PD; Schottenfeld D; Shapiro S
Am J Epidemiol; 1984 Feb; 119(2):167-76. PubMed ID: 6695896
[TBL] [Abstract][Full Text] [Related]
29. Risk of breast cancer among young women: relationship to induced abortion.
Daling JR; Malone KE; Voigt LF; White E; Weiss NS
J Natl Cancer Inst; 1994 Nov; 86(21):1584-92. PubMed ID: 7932822
[TBL] [Abstract][Full Text] [Related]
30. Cancer risk in Jewish BRCA1 and BRCA2 mutation carriers: effects of oral contraceptive use and parental origin of mutation.
Bernholtz S; Laitman Y; Kaufman B; Paluch Shimon S; Friedman E
Breast Cancer Res Treat; 2011 Sep; 129(2):557-63. PubMed ID: 21499684
[TBL] [Abstract][Full Text] [Related]
31. Oral contraceptive use and early abortion as risk factors for breast cancer in young women.
Pike MC; Henderson BE; Casagrande JT; Rosario I; Gray GE
Br J Cancer; 1981 Jan; 43(1):72-6. PubMed ID: 7459241
[TBL] [Abstract][Full Text] [Related]
32. Oral contraceptives and breast cancer: a cooperative Italian study.
La Vecchia C; Negri E; Franceschi S; Talamini R; Amadori D; Filiberti R; Conti E; Montella M; Veronesi A; Parazzini F
Int J Cancer; 1995 Jan; 60(2):163-7. PubMed ID: 7829209
[TBL] [Abstract][Full Text] [Related]
33. Organochlorines, p53 mutations in relation to breast cancer risk and survival. A Danish cohort-nested case-controls study.
Høyer AP; Gerdes AM; Jørgensen T; Rank F; Hartvig HB
Breast Cancer Res Treat; 2002 Jan; 71(1):59-65. PubMed ID: 11859874
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer risk and oral contraceptive use: results from a large case-control study.
Weinstein AL; Mahoney MC; Nasca PC; Leske MC; Varma AO
Epidemiology; 1991 Sep; 2(5):353-8. PubMed ID: 1742384
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study.
Chollet-Hinton L; Anders CK; Tse CK; Bell MB; Yang YC; Carey LA; Olshan AF; Troester MA
Breast Cancer Res; 2016 Aug; 18(1):79. PubMed ID: 27492244
[TBL] [Abstract][Full Text] [Related]
36. BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50.
Haile RW; Thomas DC; McGuire V; Felberg A; John EM; Milne RL; Hopper JL; Jenkins MA; Levine AJ; Daly MM; Buys SS; Senie RT; Andrulis IL; Knight JA; Godwin AK; Southey M; McCredie MR; Giles GG; Andrews L; Tucker K; Miron A; Apicella C; Tesoriero A; Bane A; Pike MC; ; ; Whittemore AS
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1863-70. PubMed ID: 17021353
[TBL] [Abstract][Full Text] [Related]
37. Oral contraceptives as related to cancer and benign lesions of the breast.
Fasal E; Paffenbarger RS
J Natl Cancer Inst; 1975 Oct; 55(4):767-73. PubMed ID: 1185801
[TBL] [Abstract][Full Text] [Related]
38. Oral contraceptives and breast cancer in young women.
Stadel BV; Rubin GL; Webster LA; Schlesselman JJ; Wingo PA
Lancet; 1985 Nov; 2(8462):970-3. PubMed ID: 2865503
[TBL] [Abstract][Full Text] [Related]
39. Oral contraceptives and breast cancer.
Kalache A; McPherson K; Barltrop K; Vessey MP
Br J Hosp Med; 1983 Oct; 30(4):278-83. PubMed ID: 6640197
[TBL] [Abstract][Full Text] [Related]
40. A case-control study of oral contraceptive use and breast cancer.
Hennekens CH; Speizer FE; Lipnick RJ; Rosner B; Bain C; Belanger C; Stampfer MJ; Willett W; Peto R
J Natl Cancer Inst; 1984 Jan; 72(1):39-42. PubMed ID: 6363789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
